Emily Ferris and Alex Arbuckle describe how using mint Lesion™ has enhanced their clinical trial operations, enabling “a more cooperative approach between [their] radiologists and oncologists” while simultaneously saving time and reducing costs.
Faced with a multitude of clinical trial site reads each day, Ms. Ferris and Mr. Arbuckle explain how they benefit from a more efficient workflow by using a dedicated software platform which provides a comprehensive and compliant response assessment and supports them in maintaining oversight of clinical trial imaging analysis design.
Ms. Ferris is a Lead Image Analyst and Mr. Arbuckle is a Clinical Research Imaging Core Manager at the University of Wisconsin Carbone Cancer Center.
Enhancing flexibility and communication while saving costs and time in clinical trials
Related Resources
Related Resources
University Hospital Tübingen: Study shows prediction power of clinical and CT imaging biomarkers
A recent retrospective study [1] conducted by researchers at University Hospital Tuebingen focused on identifying imaging and clinical predictors of…
Recording of RSNA 2019 AI theater presentation | Power food for AI
At this year’s RSNA, Mint Medical presented its AI approach to the audience at the AI theater. Tobias Gottmann and Aditya Jayaram highlighted how…
Potential of longitudinal data from single site and multi-center clinical trials for AI-research
Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this…